Percheron Therapeutics Ltd
ASX:PER

Watchlist Manager
Percheron Therapeutics Ltd Logo
Percheron Therapeutics Ltd
ASX:PER
Watchlist
Price: 0.009 AUD Market Closed
Market Cap: 9.8m AUD

Wall Street
Price Targets

PER Price Targets Summary
Percheron Therapeutics Ltd

There are no price targets for PER.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Percheron Therapeutics Ltd Competitors:
Price Targets
PFIZER
Pfizer Ltd
15% Upside
293480
Hana Pharm Co Ltd
48% Upside
600521
Zhejiang Huahai Pharmaceutical Co Ltd
8% Downside
AGY
Allergy Therapeutics PLC
61% Upside
PHO
Photocure ASA
41% Upside
VIRP
Virbac SA
14% Upside
WVE
WAVE Life Sciences Ltd
179% Upside
4547
Kissei Pharmaceutical Co Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
Percheron Therapeutics Ltd

For the last 8 years the compound annual growth rate for Percheron Therapeutics Ltd's revenue is -7%. The projected CAGR for the next 3 years is 207%.

-7%
Past Growth
207%
Estimated Growth
Estimates Accuracy
-81%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Percheron Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
Percheron Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PER's stock price target?
Not Available

PER doesn't have any price targets made by Wall Street professionals.

What is Percheron Therapeutics Ltd's Revenue forecast?
Projected CAGR
207%

For the last 8 years the compound annual growth rate for Percheron Therapeutics Ltd's revenue is -7%. The projected CAGR for the next 3 years is 207%.

Back to Top